NCT00984503 - Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

CicatrixWound Healing

Interventions

DRUG

Avotermin

Intradermal Juvista at 50ng/100μl/cm2 of SSG donor sites (3cm2) once just prior to wounding

DRUG

Placebo

Intradermal injection of Placebo at 100μl/cm2 of SSG donor site (3cm2) once just prior to wounding

DRUG

Avotermin

Intradermal Juvista at 50ng/100μl/cm2 of SSG donor site once just prior to wounding, followed by topical Juvista at 100ng/200μl/cm2 after wounding and again at Day 1

DRUG

Placebo

Intradermal placebo at 100μl/cm2 of SSG donor site once just prior to wounding, followed by topical placebo at 200μl/cm2 after wounding and again at Day 1

Trial Locations (1)

M13 9XX

Renovo, Manchester

All Listed Sponsors

lead

Renovo

INDUSTRY